Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Phillips Matthew V
Chief Commercial Officer at Avalo Therapeutics. Filing since 10 Dec 2018.
CIK 0001729197
Company
Date
Role
Action
Shares
Amount
Of holding
AVTX
Avalo Therapeutics, Inc.
10 Jun 2019
Chief Commercial Officer
Bought
523
$1.49K
105%
AVTX
Avalo Therapeutics, Inc.
10 Dec 2018
Chief Commercial Officer
Bought
497
$1.42K
opened
2 decisions on file.
